Urogenital schistosomiasis among pre-school and school aged children in four districts of north western Tanzania after 15 years of mass drug administration: Geographical prevalence, risk factors and performance of haematuria reagent strips.


Journal

PLoS neglected tropical diseases
ISSN: 1935-2735
Titre abrégé: PLoS Negl Trop Dis
Pays: United States
ID NLM: 101291488

Informations de publication

Date de publication:
10 2022
Historique:
received: 29 09 2021
accepted: 20 09 2022
revised: 24 10 2022
pubmed: 13 10 2022
medline: 27 10 2022
entrez: 12 10 2022
Statut: epublish

Résumé

Urogenital schistosomiasis remains as a public health problem in Tanzania and for the past 15 years, mass drug administration (MDA) targeting primary school children has remained as the mainstay for its control. However, after multiple rounds of MDA in highly risk groups, there are no data on the current status of Schistosoma haematobium in known endemic areas. Furthermore, the performance of commonly used diagnostic test, the urine reagent strips is not known after the decline in prevalence and intensities of infection following repeated rounds of treatment. Thus, after 15 of national MDA, there is a need to review the strategy and infection diagnostic tools available to inform the next stage of schistosomiasis control in the country. A analytical cross-sectional study was conducted between October and November, 2019 among pre-school (3-5years old) and school aged children (6-17 years old) living in four (4) districts with low (<10%) and moderate (10%-<50%) endemicity for schistosomiasis as per WHO classification at the start of the national control programme in 2005/06, with mean prevalence of 20.7%. A total of 20,389 children from 88 randomly selected primary schools participated in the study. A questionnaire was used to record demographic information. A single urine sample was obtained from each participant and visually examined for macrohaematuria, tested with a dipstick for micro-haematuria, to determine blood in urine; a marker of schistosome related morbidity and a proxy of infection. Infection intensity was determined by parasitological examination of the urine sample for S. haematobium eggs. Overall, mean infection prevalence was 7.4% (95%CI: 7.0-7.7, 1514/20,389) and geometric mean infection intensity was 15.8eggs/10mls. Both infection prevalence (5.9% versus 9%, P<0.001) and intensity (t = -6.9256, P<0.001) were significantly higher in males compared to females respectively. Light and heavy infections were detected in 82.3% and 17.7% of the positive children respectively. The prevalence of macrohaematuria was 0.3% and that of microhaematuria was 9.3% (95%CI:8.9-9.7). The sensitivity and specificity of the urine reagent strip were 78% (95%CI: 76.1-79.9) and 99.8% (95%CI: 99.7-99.9). Having light (P<0.001) and heavy infection intensities (P<0.001) and living in the study districts increased the odd of having microhaematuria. Predictors of S. haematobium infection were being male (P<0.003), microhaematuria (P<0.001), and living in the three study districts (P<0.001) compared to living at Nzega district. The findings provide an updated geographical prevalence which gives an insight on the planning and implementation of MDA. Comparing with the earlier mapping survey at the start of the national wide mass drug administration, the prevalence of S. haematobium infection have significantly declined. This partly could be attributed to repeated rounds of mass drug administration. The urine reagent strips remain as a useful adjunct diagnostic test for rapid monitoring of urogenital schistosomiasis in areas with low and high prevalence. Based on prevalence levels and with some schools having no detectable infections, review of the current blanket mass drug administration is recommended.

Sections du résumé

BACKGROUND
Urogenital schistosomiasis remains as a public health problem in Tanzania and for the past 15 years, mass drug administration (MDA) targeting primary school children has remained as the mainstay for its control. However, after multiple rounds of MDA in highly risk groups, there are no data on the current status of Schistosoma haematobium in known endemic areas. Furthermore, the performance of commonly used diagnostic test, the urine reagent strips is not known after the decline in prevalence and intensities of infection following repeated rounds of treatment. Thus, after 15 of national MDA, there is a need to review the strategy and infection diagnostic tools available to inform the next stage of schistosomiasis control in the country.
METHODS/FINDINGS
A analytical cross-sectional study was conducted between October and November, 2019 among pre-school (3-5years old) and school aged children (6-17 years old) living in four (4) districts with low (<10%) and moderate (10%-<50%) endemicity for schistosomiasis as per WHO classification at the start of the national control programme in 2005/06, with mean prevalence of 20.7%. A total of 20,389 children from 88 randomly selected primary schools participated in the study. A questionnaire was used to record demographic information. A single urine sample was obtained from each participant and visually examined for macrohaematuria, tested with a dipstick for micro-haematuria, to determine blood in urine; a marker of schistosome related morbidity and a proxy of infection. Infection intensity was determined by parasitological examination of the urine sample for S. haematobium eggs. Overall, mean infection prevalence was 7.4% (95%CI: 7.0-7.7, 1514/20,389) and geometric mean infection intensity was 15.8eggs/10mls. Both infection prevalence (5.9% versus 9%, P<0.001) and intensity (t = -6.9256, P<0.001) were significantly higher in males compared to females respectively. Light and heavy infections were detected in 82.3% and 17.7% of the positive children respectively. The prevalence of macrohaematuria was 0.3% and that of microhaematuria was 9.3% (95%CI:8.9-9.7). The sensitivity and specificity of the urine reagent strip were 78% (95%CI: 76.1-79.9) and 99.8% (95%CI: 99.7-99.9). Having light (P<0.001) and heavy infection intensities (P<0.001) and living in the study districts increased the odd of having microhaematuria. Predictors of S. haematobium infection were being male (P<0.003), microhaematuria (P<0.001), and living in the three study districts (P<0.001) compared to living at Nzega district.
CONCLUSION
The findings provide an updated geographical prevalence which gives an insight on the planning and implementation of MDA. Comparing with the earlier mapping survey at the start of the national wide mass drug administration, the prevalence of S. haematobium infection have significantly declined. This partly could be attributed to repeated rounds of mass drug administration. The urine reagent strips remain as a useful adjunct diagnostic test for rapid monitoring of urogenital schistosomiasis in areas with low and high prevalence. Based on prevalence levels and with some schools having no detectable infections, review of the current blanket mass drug administration is recommended.

Identifiants

pubmed: 36223393
doi: 10.1371/journal.pntd.0010834
pii: PNTD-D-21-01429
pmc: PMC9591047
doi:

Substances chimiques

Reagent Strips 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0010834

Subventions

Organisme : Department of Health
Pays : United Kingdom

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Acta Trop. 1990 Feb;47(2):91-100
pubmed: 1969705
Parasit Vectors. 2012 Nov 28;5:274
pubmed: 23192005
PLoS Negl Trop Dis. 2017 Feb 17;11(2):e0005372
pubmed: 28212414
Bull World Health Organ. 1997;75(3):247-52
pubmed: 9277012
Parasit Vectors. 2018 Oct 23;11(1):552
pubmed: 30352631
Trans R Soc Trop Med Hyg. 1997 Nov-Dec;91(6):643-6
pubmed: 9509169
Acta Trop. 2013 Nov;128(2):423-40
pubmed: 22580511
Bull World Health Organ. 1962;27:59-85
pubmed: 14005428
Acta Trop. 1993 Mar;53(1):39-50
pubmed: 8096108
Parasitology. 2006 Dec;133(Pt 6):711-9
pubmed: 16953953
Acta Trop. 2019 Feb;190:257-268
pubmed: 30261186
Am J Trop Med Hyg. 2003 Sep;69(3):318-23
pubmed: 14628951
Am J Trop Med Hyg. 2017 Dec;97(6):1810-1817
pubmed: 29016344
Trop Med Int Health. 2001 Dec;6(12):998-1007
pubmed: 11737837
Trop Med Infect Dis. 2018 Nov 11;3(4):
pubmed: 30423901
J Helminthol. 1988 Sep;62(3):213-7
pubmed: 3192912
BMC Public Health. 2017 Sep 12;17(1):703
pubmed: 28899362
East Afr Med J. 1995 Mar;72(3):180-5
pubmed: 7796771
Am J Trop Med Hyg. 1998 Mar;58(3):266-72
pubmed: 9546401
BMC Infect Dis. 2014 Mar 26;14:165
pubmed: 24666689
PLoS Negl Trop Dis. 2013 Sep 12;7(9):e2431
pubmed: 24069486
Parasit Vectors. 2016 Dec 16;9(1):646
pubmed: 27986092
BMC Infect Dis. 2004 Oct 07;4:40
pubmed: 15471549
Parasit Vectors. 2012 Dec 03;5:278
pubmed: 23206383
Parasit Vectors. 2019 Sep 5;12(1):429
pubmed: 31488219
Trop Med Int Health. 2006 Apr;11(4):490-503
pubmed: 16553932
Int J Parasitol. 2008 Mar;38(3-4):401-15
pubmed: 17920605
World Health Organ Tech Rep Ser. 2002;912:i-vi, 1-57, back cover
pubmed: 12592987
Arch Public Health. 2018 Jun 25;76:29
pubmed: 29983982

Auteurs

Humphrey D Mazigo (HD)

Department of Medical Parasitology, School of Medicine, Catholic University of Health, and Allied Sciences, Mwanza, Tanzania.
NIHR Global Health Research Unit Tackling Infections to Benefit Africa, University of Edinburgh, Ashworth Laboratories, King's Buildings, Edinburgh, United Kingdom.

Upendo J Mwingira (UJ)

National Neglected Tropical Diseases Control Programme, National Institute for Medical Research, Barack Obama Drive, Dar-Es-Salaam, Tanzania.
RTI International, Washington, United State of America.

Maria M Zinga (MM)

Department of Medical Parasitology, School of Medicine, Catholic University of Health, and Allied Sciences, Mwanza, Tanzania.

Cecilia Uisso (C)

National Neglected Tropical Diseases Control Programme, National Institute for Medical Research, Barack Obama Drive, Dar-Es-Salaam, Tanzania.

Paul E Kazyoba (PE)

National Institute for Medical Research, 3 Barack Obama Drive, Dar-Es-Salaam, Tanzania.

Safari M Kinung'hi (SM)

National Institute for Medical Research, Mwanza Centre, Mwanza, Tanzania.

Francesca Mutapi (F)

NIHR Global Health Research Unit Tackling Infections to Benefit Africa, University of Edinburgh, Ashworth Laboratories, King's Buildings, Edinburgh, United Kingdom.
Institute of Immunology and Infection Research, University of Edinburgh, Ashworth Laboratories, King's Buildings, Edinburgh, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH